Line, J., Ali, S. -E., Grice, S., & Naisbitt, D. (2023). Investigating T cell responses to a major catechin found in green tea (epigallocathechin-3-O-gallate-EGCG) in healthy donors expressing HLAB*35:01. In BRITISH JOURNAL OF PHARMACOLOGY Vol. 180 (pp. 520-521). Retrieved from https://www.webofscience.com/
Hammond, S., Olsson-Brown, A., Grice, S., & Naisbitt, D. J. (2022). Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?. CLINICAL AND EXPERIMENTAL ALLERGY, 52(5), 600-603. doi:10.1111/cea.14134
Hammond, S., Olsson-Brown, A., Grice, S., Gibson, A., Gardner, J., Castrejon-Flores, J. L., . . . Naisbitt, D. J. (2022). Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. TOXICOLOGICAL SCIENCES, 186(1), 58-69. doi:10.1093/toxsci/kfab144